| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.03▼ | 1.03▼ | 1.03▼ | 1.09▼ | 1.05▼ |
| MA10 | 1.03▼ | 1.07▼ | 1.07▼ | 1.09▼ | 1.04▼ |
| MA20 | 1.08▼ | 1.10▼ | 1.10▼ | 1.04▼ | 1.17▼ |
| MA50 | 1.13▼ | 1.14▼ | 1.10▼ | 1.05▼ | 1.35▼ |
| MA100 | 1.15▼ | 1.07▼ | 1.05▼ | 1.21▼ | 1.47▼ |
| MA200 | 1.07▼ | 1.02▲ | 1.04▼ | 1.34▼ | 1.46▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.004▼ | -0.012▼ | -0.015▼ | 0.006▲ | 0.000▼ |
| RSI | 33.693▼ | 35.261▼ | 38.161▼ | 47.591▼ | 43.177▼ |
| STOCH | 35.119 | 7.778▼ | 7.531▼ | 53.700 | 42.248 |
| WILL %R | -86.667▼ | -87.500▼ | -87.500▼ | -66.667 | -66.667 |
| CCI | -58.920 | -73.333 | -73.219 | -11.016 | -7.607 |
|
Wednesday, March 11, 2026 07:21 AM
NanoViricides (NYSE-A:NNVC) said on Wednesday it has completed manufacturing of its NV-387 oral drug product, clearing a key step toward dosing patients in an upcoming clinical trial for mpox. The ...
|
|
Saturday, February 21, 2026 08:22 AM
NanoViricides (NYSE-A:NNVC) earlier this week provided an update on the advancement of its broad-spectrum antiviral candidate NV-387, outlining progress in Mpox clinical development and confirming ...
|
|
Monday, February 09, 2026 06:08 PM
(MENAFN- Investor Brand Network) NanoViricides, Inc. (NYSE American: NNVC), a clinical-stage antiviral developer, announced that it has filed an application with the U.S. Food and Drug Administration ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 20/03/26 | 1.03 | 1.0699 | 1.003 | 1.03 | 168,538 |
| 19/03/26 | 1.11 | 1.11 | 1.00 | 1.05 | 295,905 |
| 18/03/26 | 1.13 | 1.17 | 1.11 | 1.12 | 187,900 |
| 17/03/26 | 1.12 | 1.16 | 1.11 | 1.13 | 102,500 |
| 16/03/26 | 1.20 | 1.22 | 1.11 | 1.14 | 177,320 |
| 13/03/26 | 1.16 | 1.18 | 1.08 | 1.18 | 323,300 |
| 12/03/26 | 1.19 | 1.27 | 1.13 | 1.16 | 952,461 |
| 11/03/26 | 0.99 | 1.15 | 0.9845 | 1.15 | 974,031 |
| 10/03/26 | 0.99 | 0.9981 | 0.9501 | 0.9719 | 67,660 |
| 09/03/26 | 0.95 | 1.03 | 0.91 | 0.98 | 273,765 |
|
|
||||
|
|
||||
|
|